Firefly NeuroscienceAIFF +6.61%9 Days Inventory is 36.47 as of Mar. 2026, which is 54% below its 10-year median of 79.32. GuruFocus rates AIFF with a GF Score™ of 9/100. The stock has 4 warning signs investors should review. Among 1,648 Software companies, Firefly Neuroscience ranks worse than 67.35% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Firefly Neuroscience's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.50.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Firefly Neuroscience's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.22.
Firefly Neuroscience (NAS:AIFF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Firefly Neuroscience's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Firefly Neuroscience's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Firefly Neuroscience Days Inventory Related Terms
Firefly Neuroscience Days Inventory Historical Data
* Premium members only.
The historical data trend for Firefly Neuroscience's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIFF vs CXAI, FALC, MNDO: Days Inventory Comparison
For the Software - Application subindustry, Firefly Neuroscience's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Firefly Neuroscience Days Inventory vs Software Industry
For the Software industry and Technology sector, Firefly Neuroscience's Days Inventory distribution charts can be found below:
* The bar in red indicates where Firefly Neuroscience's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Firefly Neuroscience (AIFF) has a Days Inventory of 36.47 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Firefly Neuroscience and its competitors. This is 54% below median its historical median of 79.32. Over the past decade, Firefly Neuroscience's Days Inventory has ranged from 50.84 to 79.32. According to the industry distribution chart, Firefly Neuroscience ranks #1110 out of 1648 companies in the Software industry, placing it in the top 67.4%.
Is Firefly Neuroscience's Days Inventory too high?
Firefly Neuroscience's current Days Inventory of 36.47 is 54% below median its 10-year median of 79.32. Over the past 10 years, this metric has ranged from a low of 50.84 to a high of 79.32. The Software industry median Days Inventory is 20.09. Firefly Neuroscience's value of 36.47 is 81.5% above this industry median. Based on the distribution chart, Firefly Neuroscience ranks #1110 out of 1648 companies in the Software industry, which is below the industry midpoint. Overall, Firefly Neuroscience has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Firefly Neuroscience's Days Inventory compare to CXAI and FALC?
According to the Software industry distribution chart, Firefly Neuroscience ranks #1110 out of 1648 companies for Days Inventory. This places Firefly Neuroscience in the lower half of its industry. The industry median Days Inventory is 20.09. Firefly Neuroscience's value of 36.47 is 81.5% above this benchmark. Historically, Firefly Neuroscience's own Days Inventory has ranged from 50.84 to 79.32 over the past decade. While the company's 10-year median is 79.32 vs. the industry median of 20.09, Firefly Neuroscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Software company?
The median Days Inventory among Software companies is 20.09, based on 1,648 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Firefly Neuroscience's current Days Inventory of 36.47 is 81.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Firefly Neuroscience and its competitors. For the Software industry, the median Days Inventory is 20.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Firefly Neuroscience's current Days Inventory is 36.47, which is 54% below median its own 10-year median of 79.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Firefly Neuroscience stock overvalued right now?
Firefly Neuroscience (AIFF) has a current Days Inventory of 36.47. The current Days Inventory is 36.47, which is 54% below median its 10-year median of 79.32 and 81.5% above the Software industry median of 20.09. Firefly Neuroscience's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Firefly Neuroscience (AIFF), the current Days Inventory is 36.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
9GF Score
Get the complete analysis for AIFF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIFF has been successfully added to your 
